11C-acetate PET imaging in prostate cancer
- 25 November 2006
- journal article
- editorial commentary
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (2) , 181-184
- https://doi.org/10.1007/s00259-006-0281-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Positron emission tomography with c11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomyUrology, 2006
- Eligibility and Outcomes Reporting Guidelines for Clinical Trials for Patients in the State of a Rising Prostate-Specific Antigen: Recommendations From the Prostate-Specific Antigen Working GroupJournal of Clinical Oncology, 2004
- Androgens stimulate coordinated lipogenic gene expression in normal target tissues in vivoMolecular and Cellular Endocrinology, 2003
- 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.2003
- Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patientsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003
- Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2002
- PROSTATE SPECIFIC ANTIGEN ONLY PROGRESSION OF PROSTATE CANCERJournal of Urology, 2000
- Natural History of Progression After PSA Elevation Following Radical ProstatectomyJAMA, 1999
- Radiotherapy for Isolated Increases in Serum Prostate-Specific Antigen Levels After Radical ProstatectomyMayo Clinic Proceedings, 1994
- Validation of [1-11C]acetate as a tracer for noninvasive assessment of oxidative metabolism with positron emission tomography in normal, ischemic, postischemic, and hyperemic canine myocardium.Circulation, 1990